Completed PHASE1 INTERVENTIONAL 1-arm NCT01099839

A Study to Assess Drug-Drug Interaction Between ASP1941 and Miglitol

A Phase I Study to Assess Drug-Drug Interaction Between ASP1941 and Miglitol.

Sponsor: Astellas Pharma Inc

Conditions Healthy Volunteers Pharmacokinetics of ASP1941

Interventions ASP1941 Miglitol

Updated 6 times since 2017 Last updated: Jun 8, 2010 Started: Feb 28, 2010 Primary completion: Apr 30, 2010 Completion: Apr 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Healthy Volunteers and Pharmacokinetics of ASP1941 and is currently completed. Astellas Pharma Inc leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Feb 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Astellas Pharma Inc

Data source: Astellas Pharma Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kantou, Japan